Kumar, S., Sun, J. D., Zhang, L., Mokhtari, R. B., Wu, B., Meng, F., . . . Baruchel, S. (2018). Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models(). Transl Oncol.
Παραπομπή Chicago StyleKumar, Sushil, et al. "Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models()." Transl Oncol 2018.
Παραπομπή MLAKumar, Sushil, et al. "Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models()." Transl Oncol 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.